Literature DB >> 2523210

Preincisional intraparietal Augmentin in abdominal operations.

A V Pollock1, M Evans, G M Smith.   

Abstract

A total of 624 consecutive eligible patients undergoing abdominal operations received a single preoperative dose of amoxycillin/clavulanic acid (1.2 g Augmentin) for the prophylaxis of surgical wound infection. They were randomised to have the antibiotic injected intravenously at induction of anaesthesia (n = 328) or infiltrated subcutaneously along the line of the proposed incision (n = 296). The incidence of wound infections was considerably lower in the group given the antibiotic into the abdominal wall (8.4% compared with 15.9%--chi 2 = 7.90, P = 0.005). No significant differences were found in the incidence of other major or minor infective or non-infective postoperative complications between the groups. It is concluded that preincisional intraparietal injection is more effective than intravenous injection of Augmentin for the prophylaxis of surgical wound infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523210      PMCID: PMC2498915     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  8 in total

1.  Preoperative intraincisional cefamandole reduces wound infection and postoperative inpatient stay in upper abdominal surgery.

Authors:  T V Taylor; D L Dawson; M de Silva; S J Shaw; D Durrans; D Makin
Journal:  Ann R Coll Surg Engl       Date:  1985-07       Impact factor: 1.891

2.  Peri-incisional mezlocillin versus rectal-metronidazole for wound infection prophylaxis.

Authors:  C Porteous; P M Davidson; D Rawluk; M Brown; R Scott; G Conn; A McClure; W R Murray
Journal:  J Hosp Infect       Date:  1985-12       Impact factor: 3.926

3.  Preoperative intraparietal (intra-incisional) cefoxitin in abdominal surgery.

Authors:  T V Taylor; W S Walker; R C Mason; J Richmond; D Lee
Journal:  Br J Surg       Date:  1982-08       Impact factor: 6.939

4.  Pre-incisional intraparietal injection of cephamandole: a new approach to wound infection prophylaxis.

Authors:  C P Armstrong; T V Taylor; D S Reeves
Journal:  Br J Surg       Date:  1982-08       Impact factor: 6.939

5.  Single dose antibiotic prophylaxis of surgical wound sepsis: which route of administration is best? A controlled clinical trial of intra-incisional against intravenous cephaloridine.

Authors:  M J Greenall; J E Atkinson; M Evans; A V Pollock
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

6.  Metronidazole and Augmentin in the prevention of sepsis after appendicectomy.

Authors:  J Drumm; I A Donovan; R Wise; P Lowe
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

7.  A randomized prospective trial comparing the value of intravenous and preincisional cefamandole in reducing postoperative sepsis after operations upon the gastrointestinal tract.

Authors:  J M Dixon; C P Armstrong; S W Duffy; U Chetty; G C Davies
Journal:  Surg Gynecol Obstet       Date:  1984-04

8.  Pre-operative assessment of fitness score.

Authors:  M J Playforth; G M Smith; M Evans; A V Pollock
Journal:  Br J Surg       Date:  1987-10       Impact factor: 6.939

  8 in total
  4 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  A randomized trial of one versus three doses of Augmentin as wound prophylaxis in at-risk abdominal surgery.

Authors:  T Bates; J V Roberts; K Smith; K A German
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

4.  Prevention of Surgical Site Infections and Biofilms: Pharmacokinetics of Subcutaneous Cefazolin and Metronidazole in a Tumescent Lidocaine Solution.

Authors:  Jeffrey A Klein; Loralie J Langman
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.